Back to Search
RICHARD BREYER, MD
MD
Diagnostic Radiology Physician
NPI: 1437281821Individual
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
06064353A(IN)
Research & Publications (20)
Comparison of imaging with FDG PET/CT with other imaging modalities in myeloma.
PMID 16758246·Skeletal Radiol·2006
4-observational
Protection of hippocampal neurogenesis from toll-like receptor 4-dependent innate immune activation by ablation of prostaglandin E2 receptor subtype EP1 or EP2.
PMID 19389932·Am J Pathol·2009
7-preclinical
Altered hippocampal long-term synaptic plasticity in mice deficient in the PGE2 EP2 receptor.
PMID 19012750·J Neurochem·2009
7-preclinical
Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor.
PMID 19416671·Exp Neurol·2009
7-preclinical
Therapeutic targets in prostaglandin E2 signaling for neurologic disease.
PMID 18691044·Curr Med Chem·2008
6-review
The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis.
PMID 18825663·Ann Neurol·2008
7-preclinical
Increased dietary NaCl induces renal medullary PGE2 production and natriuresis via the EP2 receptor.
PMID 18632796·Am J Physiol Renal Physiol·2008
7-preclinical
Macrophage EP4 deficiency increases apoptosis and suppresses early atherosclerosis.
PMID 19041765·Cell Metab·2008
7-preclinical
Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia.
PMID 18472336·Neurosci Lett·2008
7-preclinical
Mouse EP3 alpha, beta, and gamma receptor variants reduce tumor cell proliferation and tumorigenesis in vivo.
PMID 18230618·J Biol Chem·2008
7-preclinical
Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX-2.
PMID 17330822·Eur J Immunol·2007
7-preclinical
Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells.
PMID 17135575·J Leukoc Biol·2007
7-preclinical
Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting.
PMID 17710229·J Clin Invest·2007
7-preclinical
Deletion of prostaglandin E2 EP2 receptor protects against ultraviolet-induced carcinogenesis, but increases tumor aggressiveness.
PMID 16977324·J Invest Dermatol·2007
7-preclinical
Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages.
PMID 16338931·J Biol Chem·2006
7-preclinical
EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival.
PMID 16732324·Oncogene·2006
7-preclinical
The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia.
PMID 15930264·Cancer Res·2005
7-preclinical
Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D2 receptor CRTH2.
PMID 16030019·J Biol Chem·2005
7-preclinical
Characterization of a rabbit kidney prostaglandin F(2{alpha}) receptor exhibiting G(i)-restricted signaling that inhibits water absorption in the collecting duct.
PMID 16096282·J Biol Chem·2005
7-preclinical
Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease.
PMID 16267225·J Neurosci·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10 N GREENE ST, IMAGING SERVICE #114
BALTIMORE, MD 21201 - Phone
- (410) 605-7175
Quick Facts
- NPI
- 1437281821
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile